CLINICAL TRIALS PROFILE FOR XERAVA
✉ Email this page to a colleague
All Clinical Trials for XERAVA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT05537896 ↗ | Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia | Not yet recruiting | West Virginia University | Phase 2 | 2022-10-01 | Antibacterial prophylaxis is recommended in patients at high risk of infection, specifically patients undergoing acute leukemia induction therapy or hematopoietic stem cell transplant (HSCT) who are expected to have profound neutropenia (ANC |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for XERAVA
Condition Name
Clinical Trial Locations for XERAVA
Trials by Country
Clinical Trial Progress for XERAVA
Clinical Trial Phase
Clinical Trial Sponsors for XERAVA
Sponsor Name
